<bill session="116" type="h" number="2732" updated="2022-02-08T23:19:27Z">
  <state datetime="2019-05-14">REFERRED</state>
  <status>
    <introduced datetime="2019-05-14"/>
  </status>
  <introduced datetime="2019-05-14"/>
  <titles>
    <title type="display">LABEL Opioids Act</title>
    <title type="official" as="introduced">To amend the Controlled Substances Act to require warning labels for prescription opioids, and for other purposes.</title>
    <title type="short" as="introduced">LABEL Opioids Act</title>
    <title type="short" as="introduced">Lessening Addiction By Enhancing Labeling Opioids Act of 2019</title>
  </titles>
  <sponsor bioguide_id="S001211"/>
  <cosponsors>
    <cosponsor bioguide_id="H001081" joined="2019-12-09"/>
    <cosponsor bioguide_id="L000591" joined="2019-10-16"/>
    <cosponsor bioguide_id="M001209" joined="2019-05-14"/>
    <cosponsor bioguide_id="M001143" joined="2019-11-18"/>
    <cosponsor bioguide_id="P000258" joined="2020-01-28"/>
    <cosponsor bioguide_id="S001205" joined="2019-09-17"/>
    <cosponsor bioguide_id="S000344" joined="2020-01-28"/>
    <cosponsor bioguide_id="V000133" joined="2019-06-03"/>
    <cosponsor bioguide_id="W000826" joined="2019-06-03"/>
  </cosponsors>
  <actions>
    <action datetime="2019-05-14">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-05-14" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-05-14">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-05-15">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2019-06-26">
      <text>Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSJU" name="House Judiciary" subcommittee="" activity="Referral"/>
    <committee code="HSJU08" name="House Judiciary" subcommittee="Crime and Federal Government Surveillance" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="s" number="1449" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Crime and law enforcement"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Consumer affairs"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Health information and medical records"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2019-07-29T12:36:10Z" status="Introduced in House">Lessening Addiction By Enhancing Labeling Opioids Act of 2019 or the LABEL Opioids Act

This bill requires prescription opioids to contain a warning label specifying that the opioids may cause dependence, addiction, and overdose.</summary>
</bill>
